- Vancoplus is indicated for the treatment of serious or severe infections caused by susceptible strains of gram-positive (including methicillin-resistant strains) and gram-negative pathogens.
- Complicated Skin and skin-structure infections (including cellulitis, myositis and necrotizing fasciitis)
- Empirical therapy in meningitis, central nervous system (CNS) infection like brain abscess, suppurative intra cranial infections and Epidural abscess, Prophylaxis of shunt Infections
1.5g or 3.0g dry powder for injection
|India Patent No.||263097|
|US Patent No.||7960337|
|EU Patent No.||1848413|
|Japan Patent No.||4918502|